Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over 120 countries.<\/p>\n
The company has a strong product portfolio that includes anti-malarial, anti-emetic, anti-inflammatory, cardiovascular, anti-diabetic, anti-depressant, and anti-bacterial drugs. Some of its well-known brands include Aralen, Hydroxychloroquine Sulphate, Azithral, and Lariago. In terms of earnings, Revenue from Operations for Q3 FY23 was \u20b91,546 crore, a 8% increase from \u20b91,430.47 crore in the same period last year. The third quarter\u2019s other income, which contributed \u20b930.89 Crore to the Total Revenue. Meanwhile, the Profit Before Tax improved to \u20b9169.34 Crore from \u20b9260.66 Crore from the same quarter previous year. The Consolidated Net Profit was \u20b9107.84 crore, down 45% from \u20b9196.96 crore in the same quarter last year. This quarter\u2019s earnings per share was \u20b94.25.<\/p>\n","protected":false},"excerpt":{"rendered":"
Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over 120 countries. The company has […]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-142932","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":147519,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-industries-limited-for-q4-fy23\/","url_meta":{"origin":142932,"position":0},"title":"Earnings Summary Of Ipca Laboratories Industries Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 30, 2023","format":false,"excerpt":"Ipca Laboratories Limited is a leading pharmaceutical company headquartered in Mumbai, India. With over 75 years of experience, the company specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products. Ipca Labs has a strong presence both in the domestic market of India and in several\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141513,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-limited-q3-fy23-revenue-increased-to-%e2%82%b91546-crore\/","url_meta":{"origin":142932,"position":1},"title":"Ipca Laboratories Limited Q3 FY23; Revenue Increased To \u20b91,546 Crore","author":"Hardik Bhandare","date":"February 14, 2023","format":false,"excerpt":"Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of \u20b91,546 Crore up from \u20b91,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of \u20b9107.84 Crore, down 45% from \u20b9196.96 Crore in the same quarter of the previous year. The Earnings per Share\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/e8559177-a2aa-442a-9229-39ca4bebdf96-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167062,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q3fy25-25-rise-in-profits\/","url_meta":{"origin":142932,"position":2},"title":"Ipca Laboratories Ltd Q3FY25; 25% rise in Profits","author":"Chirag Gupta","date":"February 25, 2025","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,245.00 Crores up from \u20b92,053.00 Crore year on year, a rise of 9.35%. Total Expenses for Q3FY25 of \u20b91,897.00 Crores up from \u20b91,855.00 Crores year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142547,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-fdc-limited-for-q3-fy23\/","url_meta":{"origin":142932,"position":3},"title":"Earnings Summary Of FDC Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 22, 2023","format":false,"excerpt":"FDC Limited (NSE: FDC) is a leading Indian pharmaceutical company that specializes in the manufacturing and marketing of a wide range of prescription and OTC drugs. The company has a strong presence in India and exports its products to more than 50 countries. FDC Limited has a diversified product portfolio\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172961,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-q2-fy26-earnings-results\/","url_meta":{"origin":142932,"position":4},"title":"Ipca Laboratories Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"December 9, 2025","format":false,"excerpt":"Ipca Laboratories Ltd, engaged in manufacturing and marketing of pharmaceuticals, reported robust financial performance for Q2FY26 with revenue growth across domestic formulations, exports, and APIs. Financial Highlights: Revenues increased 8.54% year-on-year to \u20b92,556 crore from \u20b92,355 crore, with domestic formulations up 8% to \u20b91,019 crore and exports up 7% to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":181114,"url":"https:\/\/alphastreet.com\/india\/ipca-labs-posts-6-6-revenue-growth-in-q3-profit-boosted-by-one-time-asset-disposal\/","url_meta":{"origin":142932,"position":5},"title":"IPCA Labs Posts 6.6% Revenue Growth in Q3; Profit Boosted by One-Time Asset Disposal","author":"Staff Correspondent","date":"February 16, 2026","format":false,"excerpt":"IPCA Laboratories Limited (NSE: IPCALAB) on Friday reported a 31.5% year-on-year increase in consolidated net profit for the third quarter ended December 31, 2025. The result was bolstered by steady growth in its core pharmaceutical operations and a one-time gain from the disposal of assets. The Mumbai-based pharmaceutical major\u2019s board\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142932"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142932\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}